Skip to main content
Slide 1
FDG-PET Scan

FDG-PET scans are critical for early detection and monitoring of disease. Our center offers rapid results to support timely and effective treatment decisions.

Slide 2
Beta-Amyloid PET Brain Scans

Diagnosing Alzheimer’s is complex. Beta-Amyloid PET/CT imaging visualizes plaques present in the brain, which are prime suspects in damaging and killing nerve cells in Alzheimer's.

Slide 3
Neuroendocrine PET Scan

A neuroendocrine PET scan helps doctors locate tumors, assess their size and spread, and determine hormone activity, aiding in accurate detection and management.

Slide 4
PSMA for Prostate Cancer

Early detection is crucial to cancer care. The PSMA Tracer can provide a minimally invasive option to scanning for prostate cancer.

previous arrowprevious arrow
next arrownext arrow

Affordable, Top-Tier Care – Fast Results

Diagnostic testing can be stressful, but at OncoLogics, we believe in offering more than just medical care—we provide compassion, empathy, and positivity. We’re dedicated to making your experience as easy, comfortable, and positive as possible. With advanced PET technology on-site, we can get you in for an appointment quickly, ensuring you complete your scans without the need for additional appointments or travel. This convenience ensures a seamless experience, with everything you need in one location.

PET Services:

 

FDG-PET Scan:

A FDG-PET scan stands for fluorodeoxyglucose positron emission tomography. This procedure is used to detect metabolically active malignant lesions in various cancers, including lung, colorectal, lymphoma, melanoma, breast, ovarian, brain cancers, and multiple myeloma. An FDG-PET scan can also be used to stage cancer and monitor the response to therapy.

Beta-Amyloid PET Brain Scans:

Diagnosing Alzheimer’s disease can be challenging. Beta-Amyloid PET imaging helps by visualizing brain plaques, which are believed to play a key role in damaging and killing nerve cells in Alzheimer's.

Neuroendocrine PET Scan:

A PET scan is a specialized imaging test used to detect and evaluate neuroendocrine tumors, which are a type of cancer that arises from cells of the endocrine (hormonal) and nervous systems. A neuroendocrine PET scan is a powerful tool that helps doctors locate tumors, determine their size and spread (metastasis), and assess whether they are actively producing hormones, thereby aiding in the accurate detection and management of neuroendocrine tumors.

PSMA Imaging for Prostate Cancer:

A PET/CT scan using the PSMA tracer helps identify prostate cancer by injecting a tracer that attaches to cancer cells in the prostate and metastases, sending signals to the PET/CT scanner. This process provides accurate, early detection, aiding in better-informed treatment decisions.

Why Choose Us:

 

  • Convenient Appointments: We strive to schedule appointments within 24 to 48 hours. *Depending on insurance authorization and receipt of appropriate records.
  • Quick Results: Your doctor will typically receive your results within 24 to 48 hours.
  • Lower Costs: Our facility charges less than most, resulting in a lower copay for you.
  • Simple Billing: You’ll receive just one bill, unlike hospital imaging, which often involves separate bills from the hospital and radiologist.
  • Accessible Locations: Our imaging centers are conveniently located, sparing you the hassle of navigating large medical complexes.
  • Personalized Guidance: We’ll guide you through the process, explaining each step, how long it will take, and when you can expect your results.

Expert Interpretation and Seamless Delivery

Our PET scans are interpreted by some of the nation’s most experienced and sought-after PET specialists. Our radiologists tailor their reports to meet your needs and are readily available to discuss the results with you. Customized result packets are delivered to referring physicians within 24-48 hours of the scan. For urgent cases, verbal reports may be provided within hours of the scan.

PET Imaging with Lower Costs and Faster Results

Reach out to our team today.